据国家药品监督管理局近日发布通告称，经贵州省食品药品检验所等 4 家药品检验机构检验，发现 4 批次药品不符合规定。药品名称包括 A、B、C、D 四种，具体药品名称请查阅相关公告。
经国家药品监督管理局审查，这 4 批次药品均不符合规定，已被要求暂停销售并召回。药品检验机构表示，发现这些药品存在质量问题，可能对患者的健康造成威胁，需引起高度重视。
此次药品召回范围涉及 A、B、C、D 四个品种，药品生产商和销售商已被要求进行严肃整改，确保药品质量符合国家相关法规。同时，国家药品监督管理局将继续加强对药品的监管，确保人民群众用药安全有效。
英文标题：Important 通告：4 batches of medicines found to be non-compliant by the National Drug Administration
关键词：National Drug Administration, medicines, non-compliant, recall
翻译内容：
According to a recent announcement by the National Drug Administration, four batches of medicines have been found to be non-compliant by the Guizhou Province Food and Drug Administration’s testing institutions. The specific drug names are available in the related announcement.
The National Drug Administration conducted a review and found that all four batches of medicines did not meet the required standards. As a result, the agency has required the suspension of sales and the recall of the affected products. The drug testing institutions stated that they found quality issues with these medicines, which could pose a threat to public health.
The drug recall scope 涉及 A、B、C、D 四个品种，pharmaceutical manufacturers and retailers have been ordered to conduct thorough rectification to ensure the quality of the medicines meets national relevant regulations. At the same time, the National Drug Administration will continue to strengthen the supervision of drugs to ensure the safety and effectiveness of medications for the benefit of the public.
【来源】http://www.chinanews.com/life/2023/12-11/10126370.shtml
Views: 1